Cipla buys Indian plants from contractor

By Gareth Macdonald

- Last updated on GMT

Cipla buys Indian plants from contractor

Related tags Mumbai

Indian drugmaker Cipla has bought two manufacturing facilities from its contractor Okasa Pharma.

The INR100m ($16m) deal, which was detailed in a filing on the Bombay Stock Exchange (BSE)​ on Monday, adds a multi-dosage form plant in Goa and an aerosol formulations site in Satara to Cipla’s network and it being conducted by its subsidiary Medispral Laboratories.

The drugmaker said that: “A significant portion of the capacities of the two undertakings are dedicated for the manufacture of Cipla's products. Acquisition of the aforesaid undertakings is expected to yield operational synergies​.”

News of the deal comes just months after Cipla unveiled plans to invest in its UK manufacturing subsidiary and acquired fellow India-based cell banking, cell culture, purification and formulation firm Mabpharm.

Related topics Drug Delivery

Related news

Follow us


View more